P04.89
Newborn affected by other maternal noxious substances
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code P04.89 pertains to newborns who have been affected by harmful substances ingested or experienced by their mothers during pregnancy. This condition can result in various health issues for the baby, depending on the type and amount of substances involved. It’s important to understand the potential causes, symptoms, and general implications associated with this diagnosis, although specific medical treatment and management should always be guided by healthcare professionals.
Causes & Symptoms
Clinical Causes: Maternal use of illicit drugs such as cocaine, heroin, or methamphetamines during pregnancy. Exposure to certain prescription medications that are contraindicated during pregnancy. Consumption of hazardous substances like solvents, paints, or chemicals by the mother. Excessive alcohol intake by the mother during pregnancy. Use of herbal supplements or other substances without medical supervision.
Key Symptoms: Low birth weight Preterm birth Neonatal withdrawal symptoms including irritability, tremors, or feeding difficulties Respiratory issues such as apnea or irregular breathing patterns Congenital anomalies or developmental abnormalities Poor muscle tone or reflexes Jaundice or discoloration of the skin Lethargy or hyperactivity
Diagnostic & Treatment
Diagnosis Path: Diagnosis of a newborn affected by maternal noxious substances involves a combination of maternal history, clinical examination of the infant, and laboratory tests. Healthcare providers often review maternal substance use history, conduct physical exams, and may perform toxicology screening through blood, urine, or meconium tests to detect the presence of harmful substances. Ultrasound and other imaging studies may be used to assess for congenital abnormalities or complications related to in utero exposure.
Treatment Protocols: Management of infants affected by maternal noxious substances generally involves supportive care tailored to the individual needs of the baby. This may include nutritional support, treatment of withdrawal symptoms, infection control if necessary, and ongoing monitoring of development. Early intervention services may be recommended to address developmental delays or neurological concerns. The mother's health and substance use should also be addressed with medical and psychological support, emphasizing the importance of a comprehensive approach for both mother and child.
Clinical Advice & FAQs
Billing Guidance
Is P04.89 a billable ICD-10 code?
Yes, P04.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.89?
Clinical documentation must specify the nature of Newborn affected by other maternal noxious substances and any associated comorbidities for accurate reporting.
Cite this Clinical Reference